During the past decade, Univerzitna nemocnica Bratislava, Nemocnica sv Cyrila a Metoda conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Univerzitna nemocnica Bratislava, Nemocnica sv Cyrila a Metoda" are "COVID-19" (1 trials), "Diabetes Mellitus" (1 trials), "Diabetic Retinopathy" (1 trials), "Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive" (1 trials) and "Macular Edema" (1 trials). Many other conditions were trialed in "Univerzitna nemocnica Bratislava, Nemocnica sv Cyrila a Metoda" in a lesser frequency.

Most popular intervention types in "Univerzitna nemocnica Bratislava, Nemocnica sv Cyrila a Metoda" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Bosutinib" (1 trials), "Carfilzomib" (1 trials), "Dexamethasone" (1 trials), "Imatinib" (1 trials) and "Lenalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Univerzitna nemocnica Bratislava, Nemocnica sv Cyrila a Metoda" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Univerzitna nemocnica Bratislava, Nemocnica sv Cyrila a Metoda". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Univerzitna nemocnica Bratislava, Nemocnica sv Cyrila a Metoda, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Univerzitna nemocnica Bratislava, Nemocnica sv Cyrila a Metoda, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".